NEW YORK ( TheStreet) -- Geron Corporation (Nasdaq: GERN) hit a new 52-week low Wednesday as it is currently trading at $2.31, below its previous 52-week low of $2.36 with one million shares traded as of 3:56 p.m. ET. Average volume has been 1.6 million shares over the past 30 days. Geron has a market cap of $323.2 million and is part of the health care sector and drugs industry. Shares are down 53.7% year to date as of the close of trading on Tuesday. Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes.
- Practice your GERN trading strategies and win cash in our stock game.